525 related articles for article (PubMed ID: 17975790)
1. Contrast-induced nephropathy.
Pucelikova T; Dangas G; Mehran R
Catheter Cardiovasc Interv; 2008 Jan; 71(1):62-72. PubMed ID: 17975790
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease.
Toso A; Maioli M; Leoncini M; Gallopin M; Tedeschi D; Micheletti C; Manzone C; Amato M; Bellandi F
Am J Cardiol; 2010 Feb; 105(3):288-92. PubMed ID: 20102936
[TBL] [Abstract][Full Text] [Related]
3. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
Oldemeyer JB; Biddle WP; Wurdeman RL; Mooss AN; Cichowski E; Hilleman DE
Am Heart J; 2003 Dec; 146(6):E23. PubMed ID: 14661012
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.
MacNeill BD; Harding SA; Bazari H; Patton KK; Colon-Hernadez P; DeJoseph D; Jang IK
Catheter Cardiovasc Interv; 2003 Dec; 60(4):458-61. PubMed ID: 14624421
[TBL] [Abstract][Full Text] [Related]
5. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
6. Contrast-induced nephropathy: a review.
Sanaei-Ardekani M; Movahed MR; Movafagh S; Ghahramani N
Cardiovasc Revasc Med; 2005; 6(2):82-8. PubMed ID: 16263365
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiology and prevention of contrast-induced acute renal failure].
Graziani G; Degnoni V; Oldani S; Buskermolen M; Brambilla G
G Ital Nefrol; 2007; 24 Suppl 38():20-4. PubMed ID: 17922443
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
Allaqaband S; Tumuluri R; Malik AM; Gupta A; Volkert P; Shalev Y; Bajwa TK
Catheter Cardiovasc Interv; 2002 Nov; 57(3):279-83. PubMed ID: 12410497
[TBL] [Abstract][Full Text] [Related]
9. [Contrast-induced acute renal failure].
Giannattasio M
G Ital Nefrol; 2005; 22(3):217-25. PubMed ID: 16001365
[TBL] [Abstract][Full Text] [Related]
10. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.
Ferrario F; Barone MT; Landoni G; Genderini A; Heidemperger M; Trezzi M; Piccaluga E; Danna P; Scorza D
Nephrol Dial Transplant; 2009 Oct; 24(10):3103-7. PubMed ID: 19549691
[TBL] [Abstract][Full Text] [Related]
11. Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions.
Aguiar-Souto P; Ferrante G; Del Furia F; Barlis P; Khurana R; Di Mario C
Int J Cardiol; 2010 Feb; 139(1):68-74. PubMed ID: 19056138
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
[TBL] [Abstract][Full Text] [Related]
13. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
[TBL] [Abstract][Full Text] [Related]
14. Contrast-induced nephropathy.
McCullough PA; Soman SS
Crit Care Clin; 2005 Apr; 21(2):261-80. PubMed ID: 15781162
[TBL] [Abstract][Full Text] [Related]
15. The clinical and renal consequences of contrast-induced nephropathy.
Finn WF
Nephrol Dial Transplant; 2006 Jun; 21(6):i2-10. PubMed ID: 16723349
[TBL] [Abstract][Full Text] [Related]
16. Contrast-induced nephropathy.
Ray S; Dutta A
Indian Heart J; 2008; 60(2):133-8. PubMed ID: 19218722
[TBL] [Abstract][Full Text] [Related]
17. Prevention of contrast-induced nephropathy: a critical review.
Van Praet JT; De Vriese AS
Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):336-47. PubMed ID: 17565276
[TBL] [Abstract][Full Text] [Related]
18. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention.
Spargias K; Alexopoulos E; Kyrzopoulos S; Iokovis P; Greenwood DC; Manginas A; Voudris V; Pavlides G; Buller CE; Kremastinos D; Cokkinos DV
Circulation; 2004 Nov; 110(18):2837-42. PubMed ID: 15492300
[TBL] [Abstract][Full Text] [Related]
19. Contrast nephropathy: review focusing on prevention.
Maeder M; Klein M; Fehr T; Rickli H
J Am Coll Cardiol; 2004 Nov; 44(9):1763-71. PubMed ID: 15519005
[TBL] [Abstract][Full Text] [Related]
20. Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography. A randomized controlled trial and review of the current literature.
Goldenberg I; Shechter M; Matetzky S; Jonas M; Adam M; Pres H; Elian D; Agranat O; Schwammenthal E; Guetta V
Eur Heart J; 2004 Feb; 25(3):212-8. PubMed ID: 14972421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
